Skip to content

Opening book details…

Can I read Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom on EtoBox?

Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom by Hilary A. Robbins; Karine Alcala; Anthony J. Swerdlow; Minouk J. Schoemaker; Nick Wareham; Ruth C. Travis; Philip A. J. Crosbie; Matthew Callister; David R. Baldwin; Rebecca Landy; Mattias Johansson is a Medicine article available to read on EtoBox.

What is Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom about?

## Background The National Health Service England (NHS) classifies individuals as eligible for lung cancer screening using two risk prediction models, PLCOm2012 and Liverpool Lung Project-v2 (LLPv2). However, no study has compared the performance of lung cancer risk models in the UK. ## Methods We analysed current and former smokers aged 40–80 years in the UK Biobank (__N__ = 217,199), EPIC-UK (__N__ = 30,813), and Generations Study (__N__ = 25,777). We quantified model calibration (ratio of expected to observed cases, __E__/__O__) and discrimination (AUC). ## Results Risk discrimination in UK Biobank was best for the Lung Cancer Death Risk Assessment Tool (LCDRAT, AUC = 0.82, 95% CI = 0.81–0.84), followed by the LCRAT (AUC = 0.81, 95% CI = 0.79–0.82) and the Bach model (AUC = 0.80, 95% CI = 0.79–0.81). Results were similar in EPIC-UK and the Generations Study. All models overestimated risk in all cohorts, with __E__/__O__ in UK Biobank ranging from 1.20 for LLPv3 (95% CI = 1.14–1.27) to 2.16 for LLPv2 (95% CI = 2.05–2.28). Overestimation increased with area-level socioeconomic status. In the combined cohorts, USPSTF 2013 criteria classified 50.7% of future cases as screening eligi

Who reads Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Hilary A. Robbins; Karine Alcala; Anthony J. Swerdlow; Minouk J. Schoemaker; Nick Wareham; Ruth C. Travis; Philip A. J. Crosbie; Matthew Callister; David R. Baldwin; Rebecca Landy; Mattias Johansson
Publisher
Springer Science and Business Media LLC
Published
2021
Language
EN
Field
Medicine (Health Sciences)

More by Hilary A. Robbins; Karine Alcala; Anthony J. Swerdlow; Minouk J. Schoemaker; Nick Wareham; Ruth C. Travis; Philip A. J. Crosbie; Matthew Callister; David R. Baldwin; Rebecca Landy; Mattias Johansson

Browse all works by Hilary A. Robbins; Karine Alcala; Anthony J. Swerdlow; Minouk J. Schoemaker; Nick Wareham; Ruth C. Travis; Philip A. J. Crosbie; Matthew Callister; David R. Baldwin; Rebecca Landy; Mattias Johansson